CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...
CVS CEO Joyner: 'No one has demonstrated more success than the PBMs'
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
CVS exec blasts drugmakers and defends PBMs
When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.
CVS’s stock is having its best day since 1999, after more than just earnings
CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Key Takeaways The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI ...
Fierce Healthcare8h
CVS CEO Joyner mounts defense of PBM industry amid ongoing scrutiny
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...
Managed Healthcare Executive6h
David Joyner: CVS Health is on a Pharmacy Transformation Journey
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...